COMMUNIQUÉS West-GlobeNewswire
-
Publication relative à des notifications de transparence
29/06/2026 -
Publication relating to transparency notifications
29/06/2026 -
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
29/06/2026 -
Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition
29/06/2026 -
Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results
29/06/2026 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2026
29/06/2026 -
Father and son climb Kilimanjaro for Human Appeal’s humanitarian work
29/06/2026 -
EssilorLuxottica: Déclaration de transactions sur actions propres
29/06/2026 -
EssilorLuxottica: Disclosure of transactions in own shares
29/06/2026 -
Résultats AGE - 29 juin 2026
29/06/2026 -
EmblemHealth Sees 50% Increase in Member Adoption and Engagement Following Debut of Redesigned Mobile App
29/06/2026 -
BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round
29/06/2026 -
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
29/06/2026 -
TOMI Environmental Solutions Announces Definitive Agreement to Merge with Carbonium Core
29/06/2026 -
Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
29/06/2026 -
Oncotelic Announces Peer-Reviewed Validation of Deciparticle™ Platform Supporting Clinical Development of Sapu003
29/06/2026 -
Achieve Life Sciences Joins Russell 2000® Index
29/06/2026 -
Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer
29/06/2026 -
New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
29/06/2026
Pages